Navigation Links
Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum Regarding Nascobal®
Date:10/26/2010

p>About Strativa Pharmaceuticals

Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), excels at finding, enhancing, and bringing to market drugs that make a meaningful difference to patients. For more information about Strativa, visit www.strativapharma.com.

About Par Pharmaceutical Companies, Inc.

Par Pharmaceutical Companies, Inc. is a U.S.-based specialty pharmaceutical company.  Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit www.parpharm.com.

About Swedish Orphan Biovitrum

Swedish Orphan Biovitrum is a Swedish based niche specialty pharmaceutical company with an international market presence.  The company is focused on providing and developing specialist pharmaceuticals for rare disease patients with high medical needs.  The portfolio consists of about 60 marketed products and an emerging late stage clinical development pipe-line.  The focus areas are: hemophilia, inflammation/autoimmune diseases, fat malabsorption, cancer supportive care and inherited metabolic disorders.

Swedish Orphan Biovitrum had pro-forma revenues 2009e of about 2 billion SEK and approximately 500 employees.  The head office is located in Sweden and the share (STO: SOBI) is listed on NASDAQ OMX Stockholm.  For more information, please visit www.Sobi.com.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statemen
'/>"/>

SOURCE Strativa Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
2. Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
3. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
4. Strativa Pharmaceuticals Provides Product Pipeline Update
5. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
6. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
7. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
8. Celtic Therapeutics and Resolvyx Pharmaceuticals Announce an Alliance in Ophthalmology
9. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
10. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
11. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Viral hepatitis is an asymptomatic disease ... of those with hepatitis C are unaware they have the ... Awareness Day in the U.S. House of Representatives will take ... Foyer of the Rayburn House Office Building in ... for the Study of Liver Diseases ( AASLD ) is ...
(Date:5/22/2013)... WHITE PLAINS, N.Y. , May 22, 2013 /PRNewswire/ ... $6 million to Valor Biotherapeutics, LLC, a ... completion of pre-clinical development, manufacturing, and a Phase I ... change the poor outcomes faced by many patients with ... with rituximab. Valor,s protein, IGN002, is ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... clinical data presented from the DEFLECT-I study demonstrates that ... brain lesion volume during TAVR (Transcatheter Aortic Valve Replacement) ... Heart Scientific Advisory Board announces consensus on the importance ... the importance and need for cerebral protection during cardiovascular ...
Breaking Medicine Technology:Hepatitis Awareness: Bringing Attention to a Silent Epidemic 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... BETHESDA, Md. , July 22 At two Food ... Vice President, Pharmaceutical Risk Management Services of Pinney ... ensure that Risk Evaluation and Mitigation Strategies (REMS) benefit patient safety ... , ...
... , WOODCLIFF LAKE, N.J. , July 22 Par ... Patrick J. Zenner has been elected to the company,s board of ... Committee and the Corporate Development Review Committee.   , ... Mr. Zenner retired in January 2001 ...
Cached Medicine Technology:Expert Challenges FDA to Bring Predictability, Feasibility, and Transparency to Drug Risk Management Process 2Patrick J. Zenner Elected to Board of Directors of Par Pharmaceutical Companies, Inc. 2
(Date:5/22/2013)... May 22, 2013 Hurricane preparation isn’t ... home. That’s why Amica Insurance is reminding ... the upcoming hurricane season. , “An important part of ... Cook, a senior assistant vice president at Amica Insurance. ... before the threat of a storm.” , Flood damage ...
(Date:5/22/2013)... trustworthy, loving child care is one of the most important ... parents in their search, Paty’s Daycare has launched a ... staff and much more. , “Our new website is vibrant, ... Patricia “Auntie Paty” Sutton, founder of Paty’s Daycare. “Just as ... from the first time that you walk through the front ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... who die each year awaiting an organ donation dropped ... numbers of children are receiving donor organs. During ... expanded to include not just patients who,ve experienced brain ... death." But it,s unclear how much that shift ...
(Date:5/22/2013)... oil supplements could help reduce the risk for ... The supplements, also known as omega-3 fatty acids, ... linked to insulin sensitivity, Harvard researchers found. Higher ... also been linked to a lower risk for ... fish oil increased circulating adiponectin, whether similar effects ...
Breaking Medicine News(10 mins):Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2
... Heart attacks in women go largely unrecognized 30 to ... warning signs and fail or delay getting help, run the ... University and SUNY Upstate Medical University have developed an educational ... ultimately, save lives. Women often don,t have the same ...
... (HealthDay News) -- Two-thirds of driving-age American teens with ... plan to drive, and these teens have a number ... with high-functioning autism spectrum disorders, or HFASDs, have subtle ... They also have difficulty regulating emotions. Many of ...
... (Jan. 12, 2012) Using two cell ... breast cancer lymph node metastases, researchers at Moffitt ... have developed targeted, fluorescent molecular imaging probes that ... The new procedure could spare breast cancer patients ...
... how the brain reconfigures its connections to minimize distractions and ... order to behave efficiently, you want to process relevant sensory ... your current situation," said Joy Geng, assistant professor of psychology ... For example, a flashing road sign alerts us to traffic ...
... , THURSDAY, Jan. 12 (HealthDay News) -- The ... HIV-infected person is the single most important risk factor for ... study of heterosexual couples has found. The research, published ... , also confirmed that the use of condoms significantly reduces ...
... enrollees cost them less, Medicare Advantage plans would profit ... strictly forbids practices such as denying coverage based on ... membership is to design insurance benefits that attract the ... 12, 2012, edition of the New England Journal ...
Cached Medicine News:Health News:Educating women about heart attacks could save lives 2Health News:Educating women about heart attacks could save lives 3Health News:Little Known About How Autism Affects Teen Drivers: Researchers 2Health News:Researchers find new, noninvasive way to identify lymph node metastasis 2Health News:Partner's 'Viral Load' a Major Factor in HIV Transmission: Study 2Health News:Gym benefits help Medicare plans recruit healthy seniors 2Health News:Gym benefits help Medicare plans recruit healthy seniors 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: